Federal R&D, Drug Discovery, and Pricing [electronic resource] : Insights from the NIH-University-Industry Relationship
- Corporate Author:
- Library of Congress. Congressional Research Service
- [Place of publication not identified] : [publisher not identified], 2009.
- Physical Description:
- 31 pages : digital, PDF file
- Explores reasons behind Government funding of R&D and subsequent efforts to facilitate private sector commercialization of the results of such work. Examines the manner in which NIH supports research to encourage the development of new pharmaceuticals and therapeutics through cooperative activities with academia, industry, and Government. Discusses whether or not use of the results of Federal R&D enterprise warrants Government input into price decisions made by the private sector. Addresses concerns surrounding innovation in health-related areas within the context of the Government's role in facilitating technological progress.
- Related Titles:
- ProQuest U.S. Congressional Research Digital Collection
- Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC.
AVAILABLE ONLINE TO AUTHORIZED PSU USERS.
- Technical Details:
- System requirements: PDF reader software.
View MARC record | catkey: 10125768